The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary-Reference-Cited by-同舟云学术

The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary

Published:2021-01-11 Issue:8 Volume:148 Page:2036-2047
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wang Bing¹,Yao Jianfei²,Ma Ruiqing¹,Liu Danni²,Lu Yiyan¹,Shi Guanjun¹,An Lubiao¹,Xia Ao¹,Chen Feng¹,Pang Shaojun¹,Zhai Xichao¹,Liu Guifeng²,Chen Shifu²,Xu Mingyan²,Song Lele²³^ORCID,Xu Hongbin¹

Affiliation:

1. Department of Myxoma Aerospace Center Hospital Beijing China

2. HaploX Biotechnology, Co., Ltd Shenzhen China

3. Department of Radiotherapy the Eighth Medical Center of the Chinese PLA General Hospital Beijing China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33460

Reference34 articles.

1. Pseudomyxoma Peritonei

2. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia

3. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases

4. Toward the molecular dissection of peritoneal pseudomyxoma

5. Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudomyxoma Peritonei Arising From a Mucinous Ovarian Borderline Tumor Treated With Paclitaxel, Cisplatin, and Bevacizumab: A Case Report;Cureus;2024-08-23

2. MUC16: clinical targets with great potential;Clinical and Experimental Medicine;2024-05-17

3. Ovarian Causes of Pseudomyxoma Peritonei (PMP)—A Literature Review;Cancers;2024-04-09

4. WITHDRAWN: Characterization of mutational landscape reveals influencing factors for therapeutic response and prognosis of colorectal cancer patients with synchronous liver metastases underwent simultaneous resection of primary and metastatic lesions;Surgery Open Science;2024-01

5. Rapid recurrence of a ruptured mucinous borderline ovarian tumor harboring K-RAS mutation followed by progression into anaplastic carcinoma with TP53 mutation;Heliyon;2022-10